August 28, 2026
Revier Therapeutics
Revier Therapeutics, a Heidelberg-based BioTech company, is advancing disease-modifying therapies for patients with cardiometabolic disease.
- Round
- Seed
- Amount raised
- $6.5M
- Lead investor
- KHAN Technology Transfer Fund II
- Industry
- Biotech, Pharmaceuticals, Healthcare
- Headquarters
- Heidelberg, Germany
- Employees
- —
- Website
- revier.bio/#home
- View profile →
Other investors
- High-Tech Gründerfonds (HTGF)
- VORNvc
- Revier Invest Heidelberg
Source: EU-Startups